Please login to the form below

National Cancer Institute

This page shows the latest National Cancer Institute news and features for those working in and with pharma, biotech and healthcare.

AZ nabs US approval for new leukaemia drug Lumoxiti

National Cancer Institute (NCI) in the US, the lead investigator in the study. ... Seattle Genetics/Takeda’s classical Hodgkin lymphoma therapy Adcetris (brentuximab vedotin) and Roche’s Kadcyla (trastuzumab emtansine) for breast cancer.

Latest news

Daily Brief: Sarepta deepens gene therapy investment, NICE changes mind on Besponsa, Digital Medicine company Akili raises $13m

Professor David Marks, Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, and transplant co-ordinator of the National Cancer Research Institute (NCRI) Adult ALL Group said the
Genetic testing: nothing to write home about?

The National Cancer Institute (NCCI) in the US has a wonderful database, the Health Information National Trends Survey (HINTS), which can call up important information as it relates to the ... like the National Cancer Institute.
ACT immunotherapy cures terminal breast cancer patient

The new approach - a modified version of a technique known as adoptive cell transfer (ACT) - is being developed by researchers at the National Cancer Institute in the US, and involves sequencing ... the DNA and RNA of tumours to try to identify mutations
Daily Brief: ASCO latest, Europe cautions on immunotherapy, rejects Duchenne treatment

Some key ASCO takeways:. Merck’s Keytruda once again demonstrated its efficacy in non-small cell lung cancer, with two new studies hitting their endpoints. ... the US National Cancer Institute sponsored trial provides definitive evidence that a simple
Celgene boosts CAR-T stake again with Bluebird Bio deal

At the time, lead investigator James Kochenderfer from the Center for Cancer Research at the National Cancer Institute in Bethesda said: “We have patients who have a sustained response and have ... and a $1.1bn agreement to acquire Impact Biomedicines

More from news
Approximately 1 fully matching, plus 77 partially matching documents found.

Latest Intelligence

30 Women Leaders in UK Healthcare (part 3)

As Director of the MRC Clinical Trials Unit she has led the National Cancer Research Network in applying clinical trials for the improvement of cancer management in the UK. ... She now sits in the House of Lords as an independent peer, and is chair of
An effective commercial model for cancer care

Treatments for cancer are among the most expensive of all, regardless of disease. ... In an online survey of 8, 411 cancer patients administered by LIVESTRONG (the Lance Armstrong Foundation) and the National Cancer Institute's Health Information
EATRIS and the new age of partnering

In a display of its global ambition, EATRIS is joining with Cancer Research UK to bring representatives of the US's National Cancer Institute to a workshop in Brussels in October ... In October the National Cancer Institute will meet with specialists -
Diagnostics are rising up the pharma value chain

According to the US National Cancer Institute, about 12 per cent of women in the general population will develop breast cancer sometime during their lives. ... lung cancer, which was backed together with Roche Diagnostics' cobas EGFR Mutation Test.
Country report: The healthcare market in France

National Cancer Institute (NCI) or the National Institute for Prevention and Education for Health (NIPEH). ... This applies to oncology drugs under France's national cancer care plan that includes fast access to new therapies.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

Cancer Research UK's Karen Vousden to join BMS board

She has more than 30 years experience in cancer research and her previous roles have included director of the Beatson Institute for Cancer Research and leadership positions at the US National ... Cancer Institute.
AZ and Medimmune bolsters immuno-oncology leadership

roles at the National Cancer Institute (NCI). ... Institut Gustave Roussy - a leading cancer-research institute.
Iris Pauporté joins OSE Immunotherapeutics

Pauporté will lead the clinical development of the firm's lung cancer candidate Tedopi, which is currently in phase III trials, and will be responsible for exploring the drug's potential ... She brings over 20 years of biomedical and clinical research
AstraZeneca appoints Sean Bohen as chief medical officer

Before joining Genentech he was a clinical instructor in oncology at Stanford University School of Medicine, a research associate at the Howard Hughes Medical Institute and a postdoctoral fellow at the ... National Cancer Institute.
JPA adds to Washington team

He also managed public health communications programmes for the Food and Drug Administration and National Cancer Institute.

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

World AIDS Day 2018: Fighting the stigma surrounding HIV

HIV infection. Nat Rev Dis Primers. 2015; 1: 15035. National Cancer Institute. ... HIV infection and cancer risk. Available at: . Accessed November 2018. UCSF Health. AIDS diagnosis. Available at: . Accessed November 2018. Avert. Symptoms and stages of
Mastering the precision medicine opportunity

The National Cancer Institute and the Centre for Disease Control both use the 4Ps model to define precision medicine, considering it a form of evidence-based medicine that is:. ... Parallel to the increasing number of testing options is the evolving
ASCO 2015: What you missed in Chicago

Specifically, we thought the checkpoint inhibitors in head and neck, lung cancer and melanoma really shone. ... The second area that really impressed me was the large National Cancer Institute (NCI) trial[3] that will look to treat patients with solid